Sanara Shareholders Overwhelmingly Approve MiMedx Merger; HSR Review Extended to October 15
SMTI has more than doubled off its 52-week low of $16.047.
Summary
Sanara MedTech shareholders approved the MiMedx acquisition with near-unanimous support, but the HSR antitrust waiting period has been extended to October 15, 2026, keeping the deal's closing timeline uncertain.
Key Events · M&A and Partnerships · SMTI
-
Merger Agreement Approved
Shareholders approved the MiMedx acquisition with 6,372,989 votes for (99.97% of votes cast), 1,944 against, and 36,494 abstaining. Quorum was 69.78% of outstanding shares.
-
Advisory Compensation Vote Passes
Proposal No. 2, the non-binding advisory vote on executive compensation related to the merger, passed with 5,841,470 votes for and 75,247 against.
-
HSR Waiting Period Extended
MiMedx voluntarily withdrew its HSR notification on September 11, 2026, and refiled on September 15, 2026, starting a new 30-day waiting period that expires October 15, 2026, unless extended or terminated earlier.
-
Deal Closing Still Pending
The merger remains subject to FTC antitrust clearance and other closing conditions. The HSR extension means the deal cannot close before October 15, 2026.
Analysis · SMTI · Industrial Applications And Services
The shareholder vote clears the final major hurdle for the MiMedx acquisition, with 99.97% of votes cast in favor of the merger agreement. First announced in July, the deal now moves closer to completion. However, the filing also reveals that the HSR antitrust review has been extended—MiMedx withdrew and refiled its notification on September 15, pushing the waiting period to October 15, 2026. Consequently, the deal is not yet cleared to close and remains subject to FTC review, a key remaining condition.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SMTI was trading at $35.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $322.9M. The 52-week trading range was $16.05 to $35.34. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.